Antifungal Cresemba (isavuconazole) approved for aspergillosis patients in China
January 13, 2022Business Services
Basilea Pharmaceutica, announced that its license partner, Pfizer, has received a Drug Approval License from the National Medical Products Administration …
PCN-101 R-ketamine Programme receives FDA Investigational New Drug clearance
January 13, 2022Business Services
The FDA has given Investigational New Drug (IND) clearance to atai Life Sciences, to conduct a clinical DDI study of …
White House announces plans to double COVID-19 tests for schools
January 12, 2022Research and Development
The Biden administration announced new plans to increase COVID-19 protection in schools in the US, as the Omicron variant continues …
South Korea Ministry of Food and Drug Safety approves Novavax COVID-19 vaccine
January 12, 2022Research and Development
Biotechnology company Novavax, alongside SK bioscience, a vaccine business subsidiary of Korea-based SK Group, announced that South Korea’s Ministry of …
WHO experts warn against repeated boosters as strategy against COVID-19
January 12, 2022Research and Development
Repeating booster doses of the original COVID-19 vaccines is not a viable strategy against emerging variants, WHO has shared, predicting …
MHRA Approves Vertex’s Kaftrio combination with ivacaftor for Children With cystic fibrosis
January 12, 2022Research and Development
Vertex Pharmaceuticals have announced the MHRA approval of the label extension of Kaftrio® (ivacaftor/tezacaftor/elexacaftor) in a combination regimen with ivacaftor, …
Latest study shows positive results of CanSinoBIO’s inhaled COVID-19 vaccine as booster
January 11, 2022Manufacturing and Production
CanSino Biologics has announced that a heterologous booster with one dose of the Inhalation Convidecia for adults aged 18 years …
Novartis to seek FDA Emergency Use Approval approval for new COVID-19 therapy
January 11, 2022Manufacturing and Production
Novartis shared on the 10 January, that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep, has prompted …
Largest Phase III hemophilia trial produces positive results
January 11, 2022Manufacturing and Production
BioMarin Pharmaceutical has revealed positive results from its ongoing Phase III GENEr8-1 trial on the viability of valoctocogene roxaparvovec as …
Pfizer’s Omicron vaccine to begin human trials late January
January 11, 2022Manufacturing and Production
Albert Bourla, the CEO of Pfizer, said a COVID-19 vaccine specifically targeting the Omicron variant of the virus, alongside other …
Trial finds new CAR T-cell therapy is effective at killing cancer cells
January 10, 2022Sales and Marketing
A Phase I clinical trial funded by the NIHR Invention for Innovation (i4i) programme, and supported by the NIHR UCLH …
European Commission approves Lumykras for lung cancer patients
January 10, 2022Sales and Marketing
The European Commission (EC) has granted conditional marketing authorisation for Lyumykras (sotorasib), a first-in-class KRAS inhibitor, for the treatment of …
FDA approval of QUVIVIQ (daridorexant) for the treatment of insomnia
January 10, 2022Sales and Marketing
Idorsia Ltd has announced the FDA approval of QUVIVIQ™ (daridorexant) 25 mg and 50 mg for the treatment of adult …
Phase III trial into lebrikizumab shows positive results for atopic dermatitis patients
January 10, 2022Sales and Marketing
Almirall has reported positive results from their Phase III trial into lebrikizumab, which demonstrated significant improvement and itch relief when …
Canada to procure 20,000 doses of GSK COVID-19 antibody therapy
January 7, 2022Medical Communications
GlaxoSmithKline Plc. has shared that it has signed agreements with the Government of Canada to supply 20,000 doses of Sotrovimab, …
Judge orders FDA to produce Pfizer safety data in eight months
January 7, 2022Medical Communications
A federal judge has ordered the FDA to make public tens of thousands of more pages on the data it …
J&J COVID-19 vaccine shows protection against breakthrough infection for up to six months
January 7, 2022Medical Communications
J&J have announced new results from the largest study to date on the durability of COVID-19 vaccines in the US. …
Neurimmune and AstraZeneca collaborate to develop human monoclonal antibody
January 7, 2022Medical Communications
Neurimmune AG announced that it has entered into an exclusive global collaboration and license agreement with Alexion, AstraZeneca Rare Disease …
FDA grant Breakthrough Therapy Designation to telisotuzumab vedotin
January 6, 2022Business Services
AbbVie’s investigational telisotuzumab vedotin has been granted Breakthrough Therapy Designation by the FDA for the treatment of patients with advanced …
Cyclenium Pharma and Vuja De Sciences collaborate on oncology drug discovery
January 6, 2022Business Services
Cyclenium Pharma, an emerging pharmaceutical company, have announced a collaboration with Vuja De Sciences, to screen and optimise lead candidates …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
